Eligible patients had received chemotherapy for malignancy or had undergone hematopoietic stem-cell transplantation, and presented with neutropaenia (< 500 cells/mm3 for 96 hours) and fever (> 38.0°C) not responding to ≥ 96 hours of parenteral antibacterial therapy.